Want to join the conversation?
$CBG's fee revenue increased 18% in the Americas and 29% in EMEA with healthy gains across the region including France, Germany, Netherlands, Spain, Switzerland and UK. In APAC, fee revenue rose 22% with growth led by Australia, Greater China and India. Normalized EBITDA increased 18% in Americas, 70% in EMEA and 54% in APAC.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?